Hybrid revascularisation in multivessel coronary artery disease
Selected in European Journal of Cardio-Thoracic Surgery by Rylski
Alberto Repossini, Maurizio Tespili, Antonio Saino, Igor Kotelnikov, Annalisa Moggi, Lorenzo Di Bacco, Claudio Muneretto
Eur J Cardiothorac Surg (2013) 44 (2): 288-294
Latest contributionsOutcome after coronary artery bypass grafting and percutaneous coronary intervention in patients with stage 3b-5 chronic kidney disease MitraClip therapy and surgical edge-to-edge repair in patients with severe left ventricular dysfunction and secondary mitral regurgitation: mid-ter... Suprasternal direct aortic approach transcatheter aortic valve replacement avoids sternotomy and thoracotomy: first-in-man experience
Minimally invasive hybrid revascularization (MIHR) by means of the left mammary artery on the left anterior descending artery (minimally invasive direct coronary artery bypass – MIDCAB) combined with percutaneous coronary interventions (PCI) is an alternative to conventional coronary artery bypass grafting or multiple PCI.
- 166 patients underwent MIHR at a single institution
- 4 patients were conversed to sternotomy due to adhesions
- 106 underwent PCI prior to MIDCAB and remaining 60 after MIDCAB
- There were no intraoperative complications and no mortality
- In-hospital mortality was 1.2% (2/166)
- Complete revascularisation was achieved in all patients
- During the mean follow-up of 4.5 ± 2.3 years 5 patients died of cardiac and 3 of non-cardiac causes. In those with follow-up angiography (n=20) 100% patency rate of LIMA-LAD graft was observed
The authors presented excellent perioperative and long-term results for MIHR – hybrid coronary revascularisation, which combines the most proven efficacious treatment of cardiac surgeons and interventional cardiologist, that is minimally-invasive coronary artery bypass on LAD and PCI for non-LAD lesions. This promising strategy integrates all the advantages of both techniques and is currently applied usually in high-risk patients. Reported revascularisation strategy shows again that close cooperation between cardiac surgeons and interventional cardiologists is mandatory to achieve the best results in coronary artery disease treatment.